Latest Breaking News On - Certara drug development solutions - Page 1 : comparemela.com

Acumen Pharmaceuticals : CTAD Symposium Presentation 2023 -October 27, 2023 at 10:37 am EDT

INTERCEPT-AD phase 1 insights and findings from the investigation of ACU193, a monoclonal antibody.

United statesSanjiv sharma cenexelEric siemersDavid weisman abingtonStephen sallowayDiana kerwinMaria johnsonMichaelis menten emaxKimball johnsonGustavo alva hoagShirley valdez arroyo santos research centerMohammad reza bolouri alzheimer memory centerEric carbonell combined researchResearch atlantaAcumen pharmaceuticalsAlida reinoso columbus clinical services

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalPatrick smithAriane lovellSheila rocchioHealth canadaRegulatory sciences medical affairs at certaraCertara incTherapeutic goods administrationRegulatory agencyEuropean medicines agencyCertara drug development solutionsDrug administrationInvestigational new drugClinical trial applicationNew drug applicationsMarketing authorization applications